PAMCX
Price
$102.55
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
VMGIX
Price
$92.97
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Ad is loading...

PAMCX vs VMGIX

Header iconPAMCX vs VMGIX Comparison
Open Charts PAMCX vs VMGIXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$102.55
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Growth Index Investor
Price$92.97
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PAMCX vs VMGIX Comparison Chart
Loading...
VS
PAMCX vs. VMGIX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a StrongBuy and VMGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31B vs. VMGIX (25.8B). VMGIX pays higher dividends than PAMCX: VMGIX (0.57) vs PAMCX (0.00). PAMCX was incepted earlier than VMGIX: PAMCX (24 years) vs VMGIX (18 years). PAMCX is a more actively managed with annual turnover of: 21.70 vs. VMGIX (14.00). PAMCX has a lower initial minimum investment than VMGIX: PAMCX (2500) vs VMGIX (3000). VMGIX annual gain was more profitable for investors over the last year : 18.90 vs. PAMCX (10.53). VMGIX return over 5 years is better than : 58.81 vs. PAMCX (11.14).
PAMCXVMGIXPAMCX / VMGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years18 years-
Gain YTD7.9367.902100%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets31B25.8B120%
Annual Yield % from dividends0.000.57-
Returns for 1 year10.5318.9056%
Returns for 3 years-16.76-3.65460%
Returns for 5 years11.1458.8119%
Returns for 10 years34.74144.4524%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TFX241.530.09
+0.04%
Teleflex
CGNT6.71-0.10
-1.47%
Cognyte Software Ltd
LFST6.72-0.11
-1.61%
LifeStance Health Group
QLGN0.17N/A
-2.03%
Qualigen Therapeutics
CRDF2.47-0.07
-2.76%
Cardiff Oncology